Barrett Asset Management’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Barrett Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,950	Closed	-$64K	–	409
2021 Q4	$64K	Hold	7,950	–	–	﹤0.01%	361
2021 Q3	$77K	Buy	+7,950	New	+$74.4K	﹤0.01%	272
2016 Q1	–	Sell	-109	Closed	-$7K	–	413
2015 Q4	$7K	Buy	+109	New	+$6.74K	﹤0.01%	289
2013 Q3	–	Sell	-42,660	Closed	-$1.67M	–	345
2013 Q2	$1.67M	Buy	+42,660	New	+$1.66M	0.17%	76

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Barrett Asset Management's TEVA Position: Q1 2022 in Review

Barrett Asset Management sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q1 2022, closing a stake of 7,950 shares — an estimated $64K sold.

Barrett Asset Management first reported a position in TEVA in Q2 2013 and held it in 4 quarters. The position peaked at $1.67M in Q2 2013. 438 funds tracked by Wall St. Rank hold TEVA as of Q1 2022.

Barrett Asset Management reported no remaining Teva Pharmaceutical Industries Limited position as of Q1 2022 after selling out during the quarter.
Barrett Asset Management sold 7,950 Teva Pharmaceutical Industries Limited shares in Q1 2022, an estimated $64K.
Barrett Asset Management first reported a position in Teva Pharmaceutical Industries Limited in Q2 2013 and held it in 4 quarters.
Barrett Asset Management's Teva Pharmaceutical Industries Limited position peaked at $1.67M in Q2 2013.
438 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q1 2022.

Based on Barrett Asset Management's 13F filing for Q1 2022, filed 16 May 2022.